ストックスクリーナーアプリを入手
19.45
1.02%
-0.17
前日終値:
$19.62
開ける：
$19.71
24時間の取引高:
5,803
Relative Volume:
0.17
時価総額：
$N/A
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-7.61%
1か月 パフォーマンス:
+4.97%
6か月 パフォーマンス:
-23.45%
1年 パフォーマンス:
-18.81%
1日の値動き範囲:
$19.45
$19.71
1週間の範囲:
$19.45
$21.17
52週間の値動き範囲:
$17.26
$25.80
Ishares Genomics Immunology And Healthcare Etf Stock (IDNA) Company Profile
IDNA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IDNA
Ishares Genomics Immunology And Healthcare Etf
|
19.59 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
274.40 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
557.70 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
560.33 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
218.92 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
478.51 | 124.43B | 0 | 0 | 0 | 0.00 |
Ishares Genomics Immunology And Healthcare Etf (IDNA) 最新ニュース
Is Healthcare Losing the Status of Safe Haven? ETFs in Focus - Zacks Investment Research
Merck Germany Buys US Cancer Drugmaker SpringWorks Therapeutics For Around $4 Billion - Benzinga
IDNA: The Cutting Edge Of Medical Science Is A Risky Investment (NYSEARCA:IDNA) - Seeking Alpha
7 Best-Performing Biotech ETFs for March 2025 - NerdWallet
Moderna, Pfizer Surge Amid CDC-WHO Split And Bird Flu; RFK Jr. Nomination Looms — A Recipe For The Perfect Storm? - Benzinga
Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies - Benzinga
Future Health: Harnessing Innovations In Healthcare - Syfe
Thematic Portfolios Re-optimisation – Capturing Emerging Trends and Maximising Growth Potential - Syfe
The Healthcare Sector: 5 Things To Know - Syfe
5 Best ETFs Tracking CRISPR Gene Editing - The Motley Fool
7 Best Biotech ETFs In Canada for March 2025 - Wealth Awesome
Top Thematic ETF Ideas for 2024: AI & More - Yahoo Canada Finance
Has Biotechnology Bottomed Out? - Master Investor
3 Healthcare Technology Stocks to Improve Lives in 2024 - InvestorPlace
IDNA ETF: Continues To Underperform, But With Long Run Potential - Seeking Alpha
Megatrends: Gene Therapy and Editing - US News Money
StockWatch: Top Biotech ETFs (Mostly) Sink Faster than the Market During Q1 - Genetic Engineering & Biotechnology News
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector - InvestorPlace
3 Themes Growth and Tech Investors May Want to Consider in 2023 - Nasdaq
7 Monkeypox Vaccine Stocks to Buy Before They Shoot Higher - InvestorPlace
Biotech ETFs Slip After Novavax Cuts 2022 Guidance - ETF Trends
RBC iShares Opens the Market - Canada NewsWire
Why ETFs may be the best way to bet on the future of biotech - The Globe and Mail
3 Biotech ETFs That Could Double Your Money by 2025 With Zero Effort - The Motley Fool
3 genome ETFs to watch in 2021 - CMC Markets
iShares Genomics Immunology And Healthcare ETF, Overshadowed But Not Irrelevant (NYSEARCA:IDNA) - Seeking Alpha
3 ETFs For More Moderna Bets - Yahoo
BlackRock dives deeper into thematic ETFs: Fund Scan - Financial Planning
iShares Lists Cybersecurity and Genomics ETFs - ETF Trends
BlackRock lists genomics and cyber security ETFs - ETF Stream
Top Healthcare ETFs Right Now • Updated Daily - Benzinga
Ishares Genomics Immunology And Healthcare Etf (IDNA) 財務データ
Ishares Genomics Immunology And Healthcare Etf (IDNA) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.19%
0.88%
大文字化:
|
ボリューム (24 時間):